GNRX
VanEck Vectors Generic Drugs ETF
GNRX
GNRX
Delisted
GNRX was delisted on the 4th of April, 2019.
3 hedge funds and large institutions have $920K invested in VanEck Vectors Generic Drugs ETF in 2016 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 2 reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
3
Holders Change
+1
Holders Change %
+50%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
IA
IFP Advisors
Tampa,
Florida
|
+$54K |
Top Sellers
| 1 |
UBS Group
Zurich,
Switzerland
|
-$452K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1.28K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $860K | -$452K | -18,950 | -34% |
|
|
IA
2
IFP Advisors
Tampa,
Florida
| $54K | +$54K | +2,250 | New |
|
|
TRCT
3
Tower Research Capital (TRC)
New York
| $6K | -$1.28K | -51 | -18% |
|